An Enhanced Package of Care to Reduce Reduce Mortality in Advanced HIV Disease
Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age18+
SponsorMakerere University
About this trial
A community-based Phase III, cluster randomized trial that seeks to determine the 24 week survival with retention in care of point of care CD4 testing with visitect and an enhanced package of screening and prophylaxis for opportunistic infections among patients with advanced HIV disease.
Eligibility criteria
Qualifiers
Age >18 years
CD4<200 cells/µL
Ability and willingness to give informed consent for the enhanced package of care arm.
Disqualifiers
Known virologic suppression (viral load <1000 copies/mL) within prior 3 months
Cannot or unlikely to attend regular clinic visits
Trial design
Treatments tested in this trial
- Enhanced care package
Treatment groups
2,400 Participants
are divided into 2 treatment groupsSponsors and collaborators
Makerere University
Lead sponsor
University of Minnesota
Collaborator
Source ClinicalTrials.gov